Dr. Reddy's Laboratories
RDY
#1770
Rank
HK$95.07 B
Marketcap
HK$113.24
Share price
0.98%
Change (1 day)
9.83%
Change (1 year)

Operating Margin for Dr. Reddy's Laboratories (RDY)

Operating Margin as of February 2026 (TTM): 22.08%

According to Dr. Reddy's Laboratories's latest financial reports and stock price the company's current Operating Margin is 22.08%. At the end of 2025 the company had an Operating Margin of 23.59%.

Operating Margin history for Dr. Reddy's Laboratories from 2002 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202523.59%-8.38%
202425.74%4.86%
202324.55%62.97%
202215.06%8.21%
202113.92%34.8%
202010.33%-29.2%
201914.59%44.47%
201810.10%-2.97%
201710.41%-40.68%
201617.54%-7.69%
201519.00%-5.59%
201420.13%7.97%
201318.64%-2.33%
201219.09%14.59%
201116.66%470.26%
20102.92%-150.77%
2009-5.75%-200.48%
20085.73%-64.49%
200716.13%107.41%
20067.78%1318.37%
20050.55%-95.66%
200412.65%-41.85%
200321.75%-28.75%
200230.53%215.09%
20019.69%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Novartis
NVS
28.85% 30.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
12.60%-42.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
15.12%-31.52%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
22.01%-0.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
7.08%-67.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.